High Free Cash Flow Stocks
HOLX is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
NASDAQ:HOLX • US4364401012
The current stock price of HOLX is 75.6 USD. Today HOLX is up by 0.01%. In the past month the price decreased by -0.09%. In the past year, price increased by 24.22%.
HOLX currently appears in the following ChartMill screener lists.
HOLX is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
ChartMill assigns a technical rating of 6 / 10 to HOLX. When comparing the yearly performance of all stocks, HOLX turns out to be only a medium performer in the overall market: it outperformed 63.73% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to HOLX. HOLX gets an excellent profitability rating and is at the same time showing great financial health properties.
On January 29, 2026 HOLX reported an EPS of 1.04 and a revenue of 1.05B. The company missed EPS expectations (-6.45% surprise) and missed revenue expectations (-4.05% surprise).
23 analysts have analysed HOLX and the average price target is 76.66 USD. This implies a price increase of 1.4% is expected in the next year compared to the current price of 75.6.
For the next year, analysts expect an EPS growth of 5.37% and a revenue growth 3.07% for HOLX
Over the last trailing twelve months HOLX reported a non-GAAP Earnings per Share(EPS) of 4.28. The EPS increased by 3.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.18% | ||
| ROA | 5.92% | ||
| ROE | 10.37% | ||
| Debt/Equity | 0.48 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.82 | 177.903B | ||
| ISRG | INTUITIVE SURGICAL INC | 45.44 | 164.959B | ||
| SYK | STRYKER CORP | 21.78 | 126.058B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.73 | 92.001B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.97 | 47.196B | ||
| IDXX | IDEXX LABORATORIES INC | 38.09 | 44.958B | ||
| BDX | BECTON DICKINSON AND CO | 11.47 | 44.516B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.93 | 32.805B | ||
| RMD | RESMED INC | 18.15 | 32.465B | ||
| DXCM | DEXCOM INC | 24.53 | 24.004B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.74 | 17.81B | ||
| PODD | INSULET CORP | 32.02 | 14.576B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,070 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
IPO: 1990-03-01
HOLOGIC INC
250 Campus Drive
Marlborough MASSACHUSETTS 01752 US
CEO: STEPHEN P. MACMILLAN
Employees: 7070
Phone: 13026587581
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,070 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
The current stock price of HOLX is 75.6 USD. The price increased by 0.01% in the last trading session.
HOLX does not pay a dividend.
HOLX has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
HOLX stock is listed on the Nasdaq exchange.
HOLOGIC INC (HOLX) currently has 7070 employees.
HOLOGIC INC (HOLX) has a market capitalization of 16.88B USD. This makes HOLX a Large Cap stock.